Resistance to immunotherapeutic antibodies in cancer : strategies to overcome resistance /
The current application of antibody-meditated targeted therapy against cancer has resulted in significant objective clinical responses, prolongation of survival and even cures. More than 20 mAbs have been approved for human use targeting a range of different cancers. However, a major drawback of mAb...
New York, NY :
|Series:||Resistance to targeted anti-cancer therapeutics ;
v. 2 |
|Online Access:||Online version|
No Tags, Be the first to tag this record!